Invitae Investor Relations Material
Latest events
Q3 2023
Invitae
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Invitae Corporation
Access all reports
Segment Data
Access more data
Revenue by
Source
Test revenue
Other
Expenses by
Financials
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people. The company offers clinical and genetic testing services to evaluate the risk of inherited conditions. It also provides diagnostic products and services, including laboratory developed tests and other diagnostic reagents to physicians and hospitals. The company offers hereditary cancer testing services under the Vectra 360 brand, prenatal testing services under the Angelica brand, and germline gene mutation screening under the Genomind brand. The company is based in San Francisco, California.
Key slides for Invitae Corporation
Q3 2023
Invitae Corporation
Q3 2023
Invitae Corporation
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States